Trajenta is used to improve blood sugar levels in adults with type 2 diabetes mellitus
Trajenta is a drug that contains the active substance Linagliptin. It is available as tablets (5 mg)
Linagliptin resides to the class of diabetes medicines called DPP-4 inhibitors. It works by increasing the amount of incretin released by the intestine. Incretin is a hormone that increases insulin levels when blood sugar is high (especially after a meal) and reduces the amount of sugar made by the body.